“The next big thing” in diabetes: clinical progress on DPP‐IV inhibitors
- 1 August 2006
- journal article
- research article
- Published by Wiley in Drug Development Research
- Vol. 67 (8), 627-642
- https://doi.org/10.1002/ddr.20138
Abstract
No abstract availableKeywords
This publication has 57 references indexed in Scilit:
- Pharmacokinetic and pharmacodynamic properties of multiple oral doses of sitagliptin, a dipeptidyl peptidase-IV inhibitor: A double-blind, randomized, placebo-controlled study in healthy male volunteersClinical Therapeutics, 2006
- METABOLISM AND PHARMACOKINETICS OF A DIPEPTIDYL PEPTIDASE IV INHIBITOR IN RATS, DOGS, AND MONKEYS WITH SELECTIVE CARBAMOYL GLUCURONIDATION OF THE PRIMARY AMINE IN DOGSDrug Metabolism and Disposition, 2003
- The Role of Dipeptidyl Peptidase IV in the Cleavage of Glucagon Family PeptidesJournal of Biological Chemistry, 2003
- Effect of Chronic Central Administration of Glucagon‐Like Peptide‐1 (7–36) Amide on Food Consumption and Body Weight in Normal and Obese RatsObesity Research, 1998
- A role for glucagon-like peptide-1 in the central regulation of feedingNature, 1996
- Dipeptidyl‐peptidase IV hydrolyses gastric inhibitory polypeptide, glucagon‐like peptide‐1(7–36)amide, peptide histidine methionine and is responsible for their degradation in human serumEuropean Journal of Biochemistry, 1993
- Truncated GLP-1 (proglucagon 78?107-amide) inhibits gastric and pancreatic functions in manDigestive Diseases and Sciences, 1993
- Preserved incretin activity of glucagon-like peptide 1 [7-36 amide] but not of synthetic human gastric inhibitory polypeptide in patients with type-2 diabetes mellitus.JCI Insight, 1993
- GLUCAGON-LIKE PEPTIDE-1 7-36: A PHYSIOLOGICAL INCRETIN IN MANThe Lancet, 1987
- Insulinotropin: glucagon-like peptide I (7-37) co-encoded in the glucagon gene is a potent stimulator of insulin release in the perfused rat pancreas.JCI Insight, 1987